Large-scale testing (Phase 3)UnknownNCT00525577What this trial is testingANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation StudyWho this might be right forDiabetes AtheroGenics 1,012
Large-scale testing (Phase 3)UnknownNCT05505994What this trial is testingThe Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminWho this might be right forDiabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+2 more Daewoong Pharmaceutical Co. LTD. 340
Not applicableStudy completedNCT06236672What this trial is testingImpact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney DiseaseWho this might be right forType 2 DiabetesChronic Kidney Diseases LMC Diabetes & Endocrinology Ltd. 348
Testing effectiveness (Phase 2)Study completedNCT02470039What this trial is testingTrial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic TherapyWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 50
Post-approval studies (Phase 4)Study completedNCT03700801What this trial is testingStudy of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic TherapyWho this might be right forType 2 Diabetes Mellitus Zhujiang Hospital 130
Early research (Phase 1)Ended earlyNCT04504045What this trial is testingMetformin's Effect on Drug Metabolism in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 University of Southern Denmark 10
Large-scale testing (Phase 3)Study completedNCT02906917What this trial is testingA 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 532
Large-scale testing (Phase 3)Study completedNCT00917267What this trial is testingExamine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian SubjectsWho this might be right forType 2 Diabetes Mellitus AstraZeneca 691
Not applicableActive Not RecruitingNCT06889909What this trial is testingComparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus (T2DM) Lahore General Hospital 102
Post-approval studies (Phase 4)Study completedNCT00548808What this trial is testingType 2 Diabetic PatientsWho this might be right forType 2 Diabetes Mellitus Eli Lilly and Company 426
Post-approval studies (Phase 4)Study completedNCT04916093What this trial is testingSafety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Beni-Suef University 60
Post-approval studies (Phase 4)Study completedNCT06266598What this trial is testingEffectiveness of Antidiabetic Treatment Applied in Childhood ObesityWho this might be right forChildhood ObesityInsulin Resistance HÜMEYRA ACIKAN 52
Testing effectiveness (Phase 2)Study completedNCT04088448What this trial is testingThe Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder PatientsWho this might be right forMajor Depressive Disorder Sadat City University 80
Testing effectiveness (Phase 2)UnknownNCT01413035What this trial is testingSafety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 DiabetesWho this might be right forType 2 Diabetes Shandong University 30
Not applicableStudy completedNCT01377935What this trial is testingRisk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsWho this might be right forDiabetes Mellitus, Type 2 AstraZeneca 113,505
Large-scale testing (Phase 3)Study completedNCT05699408What this trial is testingTo Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic DrugsWho this might be right forType 2 Diabetes Jiangsu HengRui Medicine Co., Ltd. 513
Not applicableStudy completedNCT03010956What this trial is testingChanges in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.Who this might be right forDiabetes Mellitus University of Athens 100
Large-scale testing (Phase 3)Study completedNCT01841697What this trial is testingStudy to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)Who this might be right forType 2 Diabetes Merck Sharp & Dohme LLC 642
Large-scale testing (Phase 3)Study completedNCT03285594What this trial is testingEfficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic AgentsWho this might be right forType 2 Diabetes Mellitus Lexicon Pharmaceuticals 571
Testing effectiveness (Phase 2)UnknownNCT04662866What this trial is testingEffects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting GlucoseWho this might be right forImpaired Glucose ToleranceInsulin SensitivityGlucose Metabolism Disorders Oslo University Hospital 64